6TOU
Rabies virus glycoprotein PH domain in complex with the scFv fragment of broadly neutralizing human antibody RVC20
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | SOLEIL BEAMLINE PROXIMA 2 |
| Synchrotron site | SOLEIL |
| Beamline | PROXIMA 2 |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2019-06-01 |
| Detector | DECTRIS EIGER X 9M |
| Wavelength(s) | 0.9801 |
| Spacegroup name | P 41 21 2 |
| Unit cell lengths | 81.945, 81.945, 155.927 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 46.506 - 2.587 |
| R-factor | 0.1932 |
| Rwork | 0.190 |
| R-free | 0.22500 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | Phyre2 homology model of RVC20 scFv |
| RMSD bond length | 0.003 |
| RMSD bond angle | 0.607 |
| Data reduction software | XDS |
| Data scaling software | STARANISO |
| Phasing software | PHENIX (1.10.1_2155) |
| Refinement software | PHENIX (1.10.1_2155) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 46.506 | 2.720 |
| High resolution limit [Å] | 2.587 | 2.587 |
| Rmeas | 0.106 | 3.758 |
| Rpim | 0.021 | 0.705 |
| Number of reflections | 15457 | 774 |
| <I/σ(I)> | 21.374 | |
| Completeness [%] | 89.5 | 33.3 |
| Redundancy | 25.7 | 28.1 |
| CC(1/2) | 0.999 | 0.660 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 8 | 291.15 | 0.7 uL of 18 mg/mL complex in 20 mM Tris-Cl pH 8.0, 150 mM NaCl were added to 0.7 uL of reservoir solution containing 100 mM Tris-Cl pH 8.0, 300 mM CaCl2, 22% w/v PEG4000 |






